G Remuzzi, C Zoja, E C Rossi. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultChild, PreschoolEndothelium/metabolismEndothelium/pathologyEpoprostenol/bloodEpoprostenol/deficiencyEpoprostenol/physiologyEpoprostenol/therapeutic useFemaleHemolytic-Uremic Syndrome/bloodHemolytic-Uremic Syndrome/chemically inducedHemolytic-Uremic Syndrome/pathologyHemolytic-Uremic Syndrome/therapyHumansInfantMaleMicrocirculation/pathologyMiddle AgedPurpura, Thrombotic Thrombocytopenic/bloodPurpura, Thrombotic Thrombocytopenic/pathologyPurpura, Thrombotic Thrombocytopenic/therapy
Substances: See more » Epoprostenol
Year: 1987 PMID: 3299719
Source DB: PubMed Journal: Semin Hematol ISSN: 0037-1963 Impact factor: 3.851